Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Bacil Pharma Ltd

Your Vote -

Buy

50.00%

Hold

33.33%

Sell

16.67%

50.00%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Bacil Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    23 Jul 2025, 12:11PM As of June 2025, 0.20% is owned by Indian Promoters and 99.80% by Public. <p align=justify> Top two Promoters holding highest number of shares of Baci
  • Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    18 Jul 2025, 7:50PM Compliance-Certificate under Reg.74(5) of SEBI (DP) Regulation,2018
  • Bacil Pharma - Appointment Of Ms. Chaitali Kalpataru Shah As A Executive Director And CFO Of The Company

    16 Jul 2025, 5:24PM Appointment of Ms. Chaitali Kalpataru Shah as a Executive Director and CFO of the Company
  • Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 16Th July, 2025

    16 Jul 2025, 5:20PM Outcome of Board Meeting Held on 16th July, 2025
  • Bacil Pharma - Board Meeting Intimation for We Wish To Inform You That The Meeting Of Board Of Directors Scheduled To Be Held

    11 Jul 2025, 1:04PM Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/07/2025 ,inter alia, to consider and app
  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    11 Jul 2025, 1:01PM Intimation for Resignation of CFO
  • Bacil Pharma - Revised Audited Financial Result For The Quarter And Year Ended 31St March, 2025

    26 May 2025, 8:25PM Revised Audited Financial Result for the Quarter and Year ended 31st March, 2025
  • Bacil Pharma - Revised Outcome Of Board Meeting Held On 26Th May, 2025 For Audited Financial Result For The Quarter And Year

    26 May 2025, 8:15PM Revised Outcome of Board Meeting held on 26th May, 2025 for Audited Financial Result for the Quarter and Year ended 31st March, 2025
  • Bacil Pharma - Results-Financial Results For The Year Ended 31/03/2025

    26 May 2025, 5:58PM Audited Financial Results for the year ended 31st March ,2025
  • Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Audited Financials For The Year Ended 31St

    26 May 2025, 5:46PM Outcome of Board Meeting for Approval of Audited Financials for the year ended 31st March,2025

Key fundamentals

Evaluate the intrinsic value of Bacil Pharma Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 1.3117 1.12 1.2575 1.5669 1.5554
Liabilities 1.3117 1.12 1.2575 1.5669 1.5554
Equity 6.5272 6.5271 6.5271 6.5271 6.5271
Gross Profit -0.1875 -0.2138 -3.9138 -0.3086 -0.4501
Net Profit -0.0589 -0.1018 -3.8598 -0.2392 -0.3152
Cash From Operating Activities -0.0029 -0.1474 -4.0089 -0.398 -0.3782
NPM(%) 0 0 0 0 0
Revenue 0 0 0 0 0
Expenses 0.1875 0.2138 3.9138 0.3086 0.4501
ROE(%) -0.33 -0.58 -22.24 -1.37 -1.81

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Bacil Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 885.00 -2.52 29.45 20.43 301.39 0.56
Lotus Eye Hospital and Institute Ltd 73.88 0.82 209.71 74.45 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.85 0.75 0.00 154.58 -39.50 0.00
Astec Lifesciences Ltd 892.80 -0.88 0.00 70.21 -601.21 0.00

Company Info

Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah. The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide. 2008 - Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.

Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah. The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide. 2008 - Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.

Read More

Parent Organisation

Bacil Pharma Ltd.

Founded

08/05/1987

Managing Director

NSE Symbol

FAQ

The current price of Bacil Pharma Ltd is

The 52-week high for Bacil Pharma Ltd is

The market capitalization of Bacil Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Bacil Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Bacil Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Bacil Pharma Ltd shares.

The CEO of Bacil Pharma Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT